GLOBAL OPIOID TOLERANCE TREATMENT MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Opioids are effective analgesics prescribed to people with chronic cancer and severe pain. These opioids are generally used for short period of time. If these opioids are prescribed or taken for a longer period of time or more frequent daily doses, they create opioid tolerance in patients and hence, analgesia or desired therapeutic response is not received.
Scope of the Report:
The worldwide market for Opioid Tolerance Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Opioid Tolerance Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Boehringer Ingelheim International
- GlaxoSmithKline
- Teva Pharmaceutical Industries
- Mylan
- Otsuka Pharmaceutical
- Johnson & Johnson Services
- Aurobindo Pharma
- Pfizer
- Acorda Therapeutics
- Zydus Cadila

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- NMDA Antagonists
- Alpha2-Adrenoceptor Agonists

Market Segment by Applications, can be divided into
- Hospitals and Ambulatory Surgery Centers
- Rehabilitation Centers

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioid Tolerance Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioid Tolerance Treatment, with price, sales, revenue and global market share of Opioid Tolerance Treatment in 2017 and 2018.
Chapter 3, the Opioid Tolerance Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid Tolerance Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Opioid Tolerance Treatment market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Opioid Tolerance Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.